Compare IPSC & JFU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | IPSC | JFU |
|---|---|---|
| Founded | 2019 | 2006 |
| Country | United States | China |
| Employees | N/A | N/A |
| Industry | Medicinal Chemicals and Botanical Products | Finance: Consumer Services |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 49.8M | 58.2M |
| IPO Year | 2021 | 2019 |
| Metric | IPSC | JFU |
|---|---|---|
| Price | $0.58 | $6.96 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 6 | 0 |
| Target Price | ★ $3.00 | N/A |
| AVG Volume (30 Days) | ★ 934.8K | 12.1K |
| Earning Date | 11-13-2025 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 3110.57 |
| EPS | N/A | ★ 3.04 |
| Revenue | ★ $113,337,000.00 | $44,573,690.00 |
| Revenue This Year | $1,590.09 | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $2.43 |
| Revenue Growth | ★ 4122.69 | 8.19 |
| 52 Week Low | $0.34 | $1.01 |
| 52 Week High | $1.38 | $9.48 |
| Indicator | IPSC | JFU |
|---|---|---|
| Relative Strength Index (RSI) | 56.92 | 58.72 |
| Support Level | $0.50 | $4.57 |
| Resistance Level | $0.62 | $9.48 |
| Average True Range (ATR) | 0.04 | 0.80 |
| MACD | 0.01 | 0.26 |
| Stochastic Oscillator | 64.59 | 39.01 |
Century Therapeutics Inc is a biotechnology company that specializes in leveraging adult stem cells to develop cell therapy products aimed at treating cancer, autoimmune disorders, and inflammatory diseases. Their features a genetically engineered allogeneic cell therapy platform that incorporates induced pluripotent stem cells (iPSCs), CRISPR-mediated precision gene editing, proprietary chimeric antigen receptors (CARs), Allo-EvasionTM technology, and manufacturing capabilities. This comprehensive platform seeks to address the limitations of first-generation cell therapies by optimizing cell product performance, preventing rejection by the host immune system, and reducing development and supply risks.
9F Inc is a financial account platform integrating and personalizing financial services in China. It provides a range of financial products and services across online lending, wealth management, and payment facilitation, all integrated under a single digital financial account. The company's operations are organized into Material segments, consisting of E-commerce services, technology Empowerment service and Wealth Management services, of which it derives maximum revenue from technology Empowerment service. All its revenues are generated from the People's Republic of China.